BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2014
View Archived Issues
First-in-class BRD2/3/4 inhibitor OTX-015, a potential broad-spectrum anticancer drug
Read More
Novel biomarker described for Alzheimer's disease
Read More
Ono and Gilead to collaborate on global development of BTK inhibitor
Read More
First-in-class P2X3 receptor AF-219 evaluated in refractory cough
Read More
An2-conjugated anti-HER2 MAb and MAb-drug conjugates designed to cross BBB
Read More
Dr. Reddy's completes acquisition of Habitrol
Read More
Rights to anticancer drug AUY-922 revert to Vernalis
Read More
Keryx Biopharmaceuticals launches Auryxia in the U.S.
Read More
FDA grants orphan drug designation to Nuvilex treatment for pancreatic cancer
Read More
C&C Research Laboratories patent details novel STAT3 inhibitors
Read More
Merck & Co. reports CYP3A4 inhibitors to improve PK of anti-HIV drugs
Read More
Evestra reports progesterone antagonists for breast cancer
Read More
Lupin patent divulges a novel nAChR PAM
Read More
Galapagos begins first phase I study in cystic fibrosis
Read More
Approved drug CB-008 inhibits Ebola virus in vitro
Read More
Radius Health reports phase III topline results for abaloparatide-SC
Read More
INTERCEPT Blood System receives FDA approvals and meets phase II study endpoints
Read More
Travoprost approved in the E.U. for pediatric glaucoma
Read More
Chugai seeks Japanese approval of Xeloda as postoperative adjuvant chemotherapy for gastric cancer
Read More
EMA committee recommends approval of dalbavancin
Read More
E.U. marketing approval granted for Duavive for postmenopausal estrogen deficiency symptoms
Read More
Actelion files NDA for selexipag in pulmonary arterial hypertension
Read More
Medivir selects MIV-802 as drug candidate for treatment of HCV infection
Read More
Celgene receives positive CHMP opinion to extend Revlimid indication
Read More
FDA approves Soolantra for the once-daily treatment of inflammatory lesions in rosacea
Read More
Liraglutide approved in U.S. for weight loss
Read More